BCRX SCHEDULE 13G/A: SEC filing

RA Capital Management, L.P. and affiliated reporting persons

Filed with the SEC on · accession 0001346824-26-000275

BCRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The stock moved -2.1% by the first close after the filing.

Summary of the filing

RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

shares beneficially owned$0
percent of class beneficially owned$0
Filer / reporting personRA Capital Management, L.P.
Reporting personRA Capital Healthcare Fund, L.P.
Issuer / subject companyBioCryst Pharmaceuticals, Inc.
Authorized signatory, ra capital management, l.p.Peter Kolchinsky
Reporting personRajeev Shah

How BCRX stock reacted

Close before

$7.61

Nov 13, 2026

First close after

-2.10%

$7.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BCRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BCRX?

Click here

Frequently asked questions

What did BCRX file with the SEC on Nov 16, 2026?

BCRX filed a SCHEDULE 13G/A (SEC filing). RA Capital Management, L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of 0% of BioCryst Pharmaceuticals common stock as of September 30, 2026, down from a previously reported position. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did BCRX stock react to this filing?

BCRX closed at $7.61 before the filing and $7.45 on Nov 16, 2026 (-2.10%).

Other BCRX SEC filings

Get alerts when BCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days